The Globe and Mail

Go to the Globe and Mail homepage

Jump to main navigationJump to main content

AdChoices
 

Eli Lilly and Co

NYSE: LLY
Last

(U.S.) $84.03

Today's change+0.35 +0.42%
Updated November 24 1:00 PM EST. Delayed by at least 15 minutes.
 

Eli Lilly and Co

NYSE: LLY
Last

(U.S.) $84.03

Today's change+0.35 +0.42%
Updated November 24 1:00 PM EST. Delayed by at least 15 minutes.

Eli Lilly and Co up (U.S.)$0.35

Eli Lilly and Co closed up Friday by (U.S.)$0.35 or 0.42% to (U.S.)$84.03. Over the last five days, shares have gained 1.38% and 14.25% year to date. Shares have outperformed the S&P 500 by 5.53% during the last year.

Key company metrics

  • Open(U.S.) $83.87
  • Previous close(U.S.) $83.68
  • High(U.S.) $84.17
  • Low(U.S.) $83.58
  • Bid / Ask-- / --
  • YTD % change+14.25%
  • Volume817,624
  • Average volume (10-day)2,479,584
  • Average volume (1-month)3,145,412
  • Average volume (3-month)3,446,993
  • 52-week range(U.S.) $65.66 to (U.S.) $89.09
  • Beta0.33
  • Trailing P/E40.01×
  • P/E 1 year forward19.96×
  • Forward PEG1.68×
  • Indicated annual dividend(U.S.) $2.08
  • Dividend yield2.48%
  • Trailing EPS(U.S.) $2.10
Updated November 24 1:00 PM EST. Delayed by at least 15 minutes.
S&P TSX0.21%Sector:HealthcareIndustry:Pharmaceuticals - Diversified

Latest Company News

View more News
  • Income Statement
  • Balance Sheet
  • Cash Flow
Quarter | Annual
Q3/2017Q2/2017Q1/2017Q4/2016
Fiscal Quarter Endvalues in (U.S.) $ millions unless otherwise notedSep 30, 201709/30/2017Jun 30, 201706/30/2017Mar 31, 201703/31/2017Dec 31, 201612/31/2016
Revenue5,6585,8245,2285,761
Total other revenue--------
Total revenue5,6585,8245,2285,761
Gross profit4,0924,2733,9014,295
Total cost of revenue1,5661,5521,3281,466
Total operating expense5,0534,5605,1824,884
Selling / general / administrative1,5561,7071,5451,790
Research & development1,3191,2511,2381,451
Depreciation / amortization--------
Interest expense (income), net operating--------
Unusual expense (income)612501,072178
Other operating expenses, total--------
Operating income6061,26446876
Interest income (expense), net non-operating-77-70-58-61
Gain (loss) on sale of assets--------
Other--------
Income before tax5921,26161892
Income after tax5561,008-111772
Income tax, total36253172120
Net income5561,008-111772
Total adjustments to net income--------
Net income before extra. items5561,008-111772
Minority interest--------
Equity in affiliates--------
U.S. GAAP adjustment--------
Inc. avail. to common excl. extra. items5561,008-111772
Inc. avail. to common incl. extra. items5561,008-111772
Diluted net income5561,008-111772
Dilution adjustment--------
Diluted weighted average shares1,0561,0571,0561,064
Diluted EPS excluding extraordinary itemsvalue per share0.530.95-0.100.73
Dividends per sharevalue per share0.520.520.520.51
Diluted normalized EPSvalue per share1.080.990.840.87